Article Correctness Is Author's Responsibility: Once-Daily Rivaroxaban 15 mg to 20 mg Increases Intracranial Hemorrhage Risk

The article below may contain offensive and/or incorrect content.

In the pooled analysis, once-daily 15- to 20-mg doses of rivaroxaban were significantly associated with a higher intracranial hemorrhage risk compared with aspirin.